SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Politics for Pros- moderated
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: i-node who wrote (721648)7/16/2020 11:40:32 PM
From: skinowski3 Recommendations

Recommended By
i-node
Stock Puppy
Thomas M.

  Read Replies (2) of 793771
 
It’s disappointing that while patients on HCQ did somewhat better, the improvement fell short of being statistically significant. One issue I see is their patient's age. Median age was 40 years. The interquartile age was 32 to 50 years. In other words, 25% were under 32, and 25% over 50 (usually, the bulk would be the 50 to 65 year old group.

So... the study shows that among a group of mostly young outpatients (75% under 50) Improvements in the clinical course we’re not statistically significant.

If they had more patients, maybe they’d get significant results - but, they say they couldn’t get more patients.

PS - in the discussion they actually mention that the treatment might have worked better in an older group.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News